Mount Capital’s MaxLinear MXL Stock Holding History

Mount Capital’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-44,298	Closed	-$1.5M	–	42
2022 Q2	$1.5M	Hold	44,298	–	–	0.53%	36
2022 Q1	$2.58M	Buy	+44,298	New	+$2.7M	0.75%	24

Other funds holding MXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return

Mount Capital's MXL Position: Q3 2022 in Review

Mount Capital sold out of MaxLinear (MXL) in Q3 2022, closing a stake of 44,298 shares — an estimated $1.5M sold.

Mount Capital first reported a position in MXL in Q1 2022 and held it in 2 quarters. The position peaked at $2.58M in Q1 2022. 279 funds tracked by Wall St. Rank hold MXL as of Q3 2022.

Mount Capital reported no remaining MaxLinear position as of Q3 2022 after selling out during the quarter.
Mount Capital sold 44,298 MaxLinear shares in Q3 2022, an estimated $1.5M.
Mount Capital first reported a position in MaxLinear in Q1 2022 and held it in 2 quarters.
Mount Capital's MaxLinear position peaked at $2.58M in Q1 2022.
279 funds tracked by Wall St. Rank held MaxLinear as of Q3 2022.

Based on Mount Capital's 13F filing for Q3 2022, filed 14 Nov 2022.